Antithrombin activity during the period of percutaneous coronary revascularization: Relation to heparin use, thrombotic complications and restenosis
Open Access
- 30 April 1999
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1248-1256
- https://doi.org/10.1016/s0735-1097(98)00696-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Heparin-resistant Thrombin Activity in Coronary Dissection and Threatened Coronary Occlusion During Coronary InterventionsJournal of the American College of Cardiology, 1998
- Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplastyAmerican Heart Journal, 1996
- Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplastyJournal of the American College of Cardiology, 1995
- Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectorisThe American Journal of Cardiology, 1990
- Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombusThe American Journal of Cardiology, 1990
- Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.Journal of Clinical Investigation, 1989
- Guidelines for percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1988
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977